Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jacobson, KA; Ravi, RG; Nandanan, E; Kim, HS; Moro, S; Kim, YC; Lee, K; Barak, D; Marquez, VE; Ji, XD
   Ribose modified nucleosides and nucleotides as ligands for purine receptors
   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
   
   K.A. Jacobson et al., "Ribose modified nucleosides and nucleotides as ligands for purine receptors", NUCLEOS NUC, 20(4-7), 2001, pp. 333-341
2. Savage, B; Cattaneo, M; Ruggeri, ZM
   Mechanisms of platelet aggregation
   CURRENT OPINION IN HEMATOLOGY
   
   B. Savage et al., "Mechanisms of platelet aggregation", CURR OPIN H, 8(5), 2001, pp. 270-276
3. Maayani, S; Schwarz, T; Craddock-Royal, B; Tagliente, TM
   Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro
   PLATELETS
   
   S. Maayani et al., "Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro", PLATELETS, 12(6), 2001, pp. 359-375
4. Maayani, S; Schwarz, T; Martinez, R; Tagliente, TM
   Activation of G(i)-coupled receptors releases a tonic state of inhibited platelet aggregation
   PLATELETS
   
   S. Maayani et al., "Activation of G(i)-coupled receptors releases a tonic state of inhibited platelet aggregation", PLATELETS, 12(2), 2001, pp. 94-98
5. Cattaneo, M; Gachet, C
   The platelet ADP receptors
   HAEMATOLOGICA
   
   M. Cattaneo e C. Gachet, "The platelet ADP receptors", HAEMATOLOG, 86(4), 2001, pp. 346-348
6. Lee, DK; Nguyen, T; Lynch, KR; Cheng, R; Vanti, WB; Arkhitko, O; Lewis, T; Evans, JF; George, SR; O'Dowd, BF
   Discovery and mapping of ten novel G protein-coupled receptor genes
   GENE
   
   D.K. Lee et al., "Discovery and mapping of ten novel G protein-coupled receptor genes", GENE, 275(1), 2001, pp. 83-91
7. Oury, C; Toth-Zsamboki, E; Thys, C; Tytgat, J; Vermylen, J; Hoylaerts, MF
   The ATP-gated P2X(1) ion channel acts as a positive regulator of platelet responses to collagen
   THROMBOSIS AND HAEMOSTASIS
   
   C. Oury et al., "The ATP-gated P2X(1) ion channel acts as a positive regulator of platelet responses to collagen", THROMB HAEM, 86(5), 2001, pp. 1264-1271
8. Gachet, C
   ADP receptors of platelets and their inhibition
   THROMBOSIS AND HAEMOSTASIS
   
   C. Gachet, "ADP receptors of platelets and their inhibition", THROMB HAEM, 86(1), 2001, pp. 222-232
9. Rolf, MG; Brearley, CA; Mahaut-Smith, MP
   Platelet shape change evoked by selective activation of P2X(1) purinoceptors with alpha,beta-methylene ATP
   THROMBOSIS AND HAEMOSTASIS
   
   M.G. Rolf et al., "Platelet shape change evoked by selective activation of P2X(1) purinoceptors with alpha,beta-methylene ATP", THROMB HAEM, 85(2), 2001, pp. 303-308
10. Hourani, SMO
    Discovery and recognition of purine receptor subtypes on platelets
    DRUG DEVELOPMENT RESEARCH
    
    S.M.O. Hourani, "Discovery and recognition of purine receptor subtypes on platelets", DRUG DEV R, 52(1-2), 2001, pp. 140-149
11. Jacobson, KA
    Probing adenosine and P2 receptors: Design of novel purines and nonpurinesas selective ligands
    DRUG DEVELOPMENT RESEARCH
    
    K.A. Jacobson, "Probing adenosine and P2 receptors: Design of novel purines and nonpurinesas selective ligands", DRUG DEV R, 52(1-2), 2001, pp. 178-186
12. Choi, RCY; Man, MLS; Ling, KKY; Ip, NY; Simon, J; Barnard, EA; Tsim, KWK
    Expression of the P2Y(1) nucleotide receptor in chick muscle: Its functional role in the regulation of acetylcholinesterase and acetylcholine receptor
    JOURNAL OF NEUROSCIENCE
    
    R.C.Y. Choi et al., "Expression of the P2Y(1) nucleotide receptor in chick muscle: Its functional role in the regulation of acetylcholinesterase and acetylcholine receptor", J NEUROSC, 21(23), 2001, pp. 9224-9234
13. John, GR; Simpson, JE; Woodroofe, MN; Lee, SC; Brosnan, CF
    Extracellular nucleotides differentially regulate interleukin-1 beta signaling in primary human astrocytes: Implications for inflammatory gene expression
    JOURNAL OF NEUROSCIENCE
    
    G.R. John et al., "Extracellular nucleotides differentially regulate interleukin-1 beta signaling in primary human astrocytes: Implications for inflammatory gene expression", J NEUROSC, 21(12), 2001, pp. 4134-4142
14. Krugel, U; Kittner, H; Franke, H; Illes, P
    Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo
    NEUROPHARMACOLOGY
    
    U. Krugel et al., "Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo", NEUROPHARM, 40(8), 2001, pp. 1084-1093
15. Hollopeter, G; Jantzen, HM; Vincent, D; Li, G; England, L; Ramakrishnan, V; Yang, RB; Nurden, P; Nurden, A; Julius, D; Conley, PB
    Identification of the platelet ADP receptor targeted by antithrombotic drugs
    NATURE
    
    G. Hollopeter et al., "Identification of the platelet ADP receptor targeted by antithrombotic drugs", NATURE, 409(6817), 2001, pp. 202-207
16. Mellor, EA; Maekawa, A; Austen, KF; Boyce, JA
    Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    E.A. Mellor et al., "Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells", P NAS US, 98(14), 2001, pp. 7964-7969
17. Hechler, BA; Toselli, P; Ravanat, C; Gachet, C; Ravid, K
    MpI ligand increases P2Y1 receptor gene expression in megakaryocytes with no concomitant change in platelet response to ADP
    MOLECULAR PHARMACOLOGY
    
    B.A. Hechler et al., "MpI ligand increases P2Y1 receptor gene expression in megakaryocytes with no concomitant change in platelet response to ADP", MOLEC PHARM, 60(5), 2001, pp. 1112-1120
18. Moccia, F; Baruffi, S; Spaggiari, S; Coltrini, D; Berra-Romani, R; Signorelli, S; Castelli, L; Taglietti, V; Tanzi, F
    P-2Y1 and P-2Y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells
    MICROVASCULAR RESEARCH
    
    F. Moccia et al., "P-2Y1 and P-2Y2 receptor-operated Ca2+ signals in primary cultures of cardiac microvascular endothelial cells", MICROVASC R, 61(3), 2001, pp. 240-252
19. Grobben, B; Claes, P; Van Kolen, K; Roymans, D; Fransen, P; Sys, SU; Slegers, H
    Agonists of the P2Y(AC)-receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma
    JOURNAL OF NEUROCHEMISTRY
    
    B. Grobben et al., "Agonists of the P2Y(AC)-receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma", J NEUROCHEM, 78(6), 2001, pp. 1325-1338
20. Laitinen, JT; Uri, A; Raidaru, G; Miettinen, R
    [S-35]CTP gamma S autoradiography reveals a wide distribution of G(i/o)-linked ADP receptors in the nervous system: close similarities with the platelet P2Y(ADP) receptor
    JOURNAL OF NEUROCHEMISTRY
    
    J.T. Laitinen et al., "[S-35]CTP gamma S autoradiography reveals a wide distribution of G(i/o)-linked ADP receptors in the nervous system: close similarities with the platelet P2Y(ADP) receptor", J NEUROCHEM, 77(2), 2001, pp. 505-518
21. Wittenberger, T; Schaller, HC; Hellebrand, S
    An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors
    JOURNAL OF MOLECULAR BIOLOGY
    
    T. Wittenberger et al., "An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors", J MOL BIOL, 307(3), 2001, pp. 799-813
22. Schafferhans, A; Klebe, G
    Docking ligands onto binding site representations derived from proteins built by homology modelling
    JOURNAL OF MOLECULAR BIOLOGY
    
    A. Schafferhans e G. Klebe, "Docking ligands onto binding site representations derived from proteins built by homology modelling", J MOL BIOL, 307(1), 2001, pp. 407-427
23. Foster, CJ; Prosser, DM; Agans, JM; Zhai, Y; Smith, MD; Lachowicz, JE; Zhang, FL; Gustafson, E; Monsma, FJ; Wiekowski, MT; Abbondanzo, SJ; Cook, DN; Bayne, ML; Lira, SA; Chintala, MS
    Molecular identification and characterization of the platelet ADP receptortargeted by thienopyridine antithrombotic drugs
    JOURNAL OF CLINICAL INVESTIGATION
    
    C.J. Foster et al., "Molecular identification and characterization of the platelet ADP receptortargeted by thienopyridine antithrombotic drugs", J CLIN INV, 107(12), 2001, pp. 1591-1598
24. Communi, D; Gonzalez, NS; Detheux, M; Brezillon, S; Lannoy, V; Parmentier, M; Boeynaems, JM
    Identification of a novel human ADP receptor coupled to G(i)
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    D. Communi et al., "Identification of a novel human ADP receptor coupled to G(i)", J BIOL CHEM, 276(44), 2001, pp. 41479-41485
25. Zhang, FL; Luo, L; Gustafson, E; Lachowicz, J; Smith, M; Qiao, XD; Liu, YH; Chen, GD; Pramanik, B; Laz, TM; Palmer, K; Bayne, M; Monsma, FJ
    ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    F.L. Zhang et al., "ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999", J BIOL CHEM, 276(11), 2001, pp. 8608-8615
26. Ferreira, ZS; Markus, RP
    Characterisation of P2Y(1)-like receptor in cultured rat pineal glands
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    Z.S. Ferreira e R.P. Markus, "Characterisation of P2Y(1)-like receptor in cultured rat pineal glands", EUR J PHARM, 415(2-3), 2001, pp. 151-156
27. Baurand, A; Raboisson, P; Freund, M; Leon, C; Cazenave, JP; Bourguignon, JJ; Gachet, C
    Inhibition of platelet function by administration of MRS2179, a P2Y(1) receptor antagonist
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    A. Baurand et al., "Inhibition of platelet function by administration of MRS2179, a P2Y(1) receptor antagonist", EUR J PHARM, 412(3), 2001, pp. 213-221
28. Jung, SM; Moroi, M
    Platelet collagen receptor integrin alpha(2)beta(1) activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    S.M. Jung e M. Moroi, "Platelet collagen receptor integrin alpha(2)beta(1) activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change", EUR J BIOCH, 268(12), 2001, pp. 3513-3522
29. Gershengorn, MC; Osman, R
    Minireview: Insights into G protein-coupled receptor function using molecular models
    ENDOCRINOLOGY
    
    M.C. Gershengorn e R. Osman, "Minireview: Insights into G protein-coupled receptor function using molecular models", ENDOCRINOL, 142(1), 2001, pp. 2-10
30. Sugidachi, A; Asai, F; Yoneda, K; Iwamura, R; Ogawa, T; Otsuguro, K; Koike, H
    Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747
    BRITISH JOURNAL OF PHARMACOLOGY
    
    A. Sugidachi et al., "Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747", BR J PHARM, 132(1), 2001, pp. 47-54
31. Simon, J; Vigne, P; Eklund, KM; Michel, AD; Carruthers, AM; Humphrey, PPA; Frelin, C; Barnard, EA
    Activity of adenosine diphosphates and triphosphates on a P2Y(T)-type receptor in brain capillary endothelial cells
    BRITISH JOURNAL OF PHARMACOLOGY
    
    J. Simon et al., "Activity of adenosine diphosphates and triphosphates on a P2Y(T)-type receptor in brain capillary endothelial cells", BR J PHARM, 132(1), 2001, pp. 173-182
32. Zundorf, G; Schafer, R; Vohringer, C; Halbfinger, E; Fischer, B; Reiser, G
    Novel modified adenosine 5 '-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation
    BIOCHEMICAL PHARMACOLOGY
    
    G. Zundorf et al., "Novel modified adenosine 5 '-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y(1) receptor: biotinylated analogue potentially suitable for specific P2Y(1) receptor isolation", BIOCH PHARM, 61(10), 2001, pp. 1259-1269
33. Fischer, B; Shahar, L; Chulkin, A; Boyer, JL; Harden, KT; Gendron, FP; Beaudoin, AR; Chapal, J; Hillaire-Buys, D; Petit, P
    2-thioether-5 '-O-(1-thiotriphosphate)-adenosine derivatives: New insulin secretagogues acting through P2Y-receptors
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    B. Fischer et al., "2-thioether-5 '-O-(1-thiotriphosphate)-adenosine derivatives: New insulin secretagogues acting through P2Y-receptors", ISR MED ASS, 2, 2000, pp. 92-98
34. Offermanns, S
    The role of heterotrimeric G proteins in platelet activation
    BIOLOGICAL CHEMISTRY
    
    S. Offermanns, "The role of heterotrimeric G proteins in platelet activation", BIOL CHEM, 381(5-6), 2000, pp. 389-396
35. Cattaneo, M; Lecchi, A; Lombardi, R; Gachet, C; Zighetti, ML
    Platelets from a patient heterozygous for the defect of P2(CYC) receptors for ADP have a secretion defect despite normal thromboxane A(2) production and normal granule stores - Further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2(CYC) receptors
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M. Cattaneo et al., "Platelets from a patient heterozygous for the defect of P2(CYC) receptors for ADP have a secretion defect despite normal thromboxane A(2) production and normal granule stores - Further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2(CYC) receptors", ART THROM V, 20(11), 2000, pp. E101-E106
36. Jung, SM; Moroi, M
    Activation of the platelet collagen receptor integrin alpha 2 beta 1 - Itsmechanism and participation in the physiological functions of platelets
    TRENDS IN CARDIOVASCULAR MEDICINE
    
    S.M. Jung e M. Moroi, "Activation of the platelet collagen receptor integrin alpha 2 beta 1 - Itsmechanism and participation in the physiological functions of platelets", TREND CARD, 10(7), 2000, pp. 285-292
37. Moore, D; Iritani, S; Chambers, J; Emson, P
    Immunohistochemical localization of the P2Y(1) purinergic receptor in Alzheimer's disease
    NEUROREPORT
    
    D. Moore et al., "Immunohistochemical localization of the P2Y(1) purinergic receptor in Alzheimer's disease", NEUROREPORT, 11(17), 2000, pp. 3799-3803
38. Wilde, JI; Retzer, M; Siess, W; Watson, SP
    ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation
    PLATELETS
    
    J.I. Wilde et al., "ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation", PLATELETS, 11(5), 2000, pp. 286-295
39. Gachet, C
    Platelet activation by ADP: the role of ADP antagonists
    ANNALS OF MEDICINE
    
    C. Gachet, "Platelet activation by ADP: the role of ADP antagonists", ANN MED, 32, 2000, pp. 15-20
40. Fischer, B
    P2-receptor agonists: From molecular recognition studies to potential clinical applications
    DRUG DEVELOPMENT RESEARCH
    
    B. Fischer, "P2-receptor agonists: From molecular recognition studies to potential clinical applications", DRUG DEV R, 50(3-4), 2000, pp. 338-354
41. Barnard, EA
    Imagination and reality in the search for the P2Y receptors
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM
    
    E.A. Barnard, "Imagination and reality in the search for the P2Y receptors", J AUTON NER, 81(1-3), 2000, pp. 10-15
42. Cusack, NJ; Hourani, SMO
    Platelet P2 receptors: from curiosity to clinical targets
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM
    
    N.J. Cusack e S.M.O. Hourani, "Platelet P2 receptors: from curiosity to clinical targets", J AUTON NER, 81(1-3), 2000, pp. 37-43
43. Kennedy, C
    The discovery and development of P2 receptor subtypes
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM
    
    C. Kennedy, "The discovery and development of P2 receptor subtypes", J AUTON NER, 81(1-3), 2000, pp. 158-163
44. Fagura, MS; Jarvis, GE; Dougall, IG; Leff, P
    Adventures in the pharmacological analysis of P2 receptors
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM
    
    M.S. Fagura et al., "Adventures in the pharmacological analysis of P2 receptors", J AUTON NER, 81(1-3), 2000, pp. 178-186
45. von Kugelgen, I; Wetter, A
    Molecular pharmacology of P2Y-receptors
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    I. von Kugelgen e A. Wetter, "Molecular pharmacology of P2Y-receptors", N-S ARCH PH, 362(4-5), 2000, pp. 310-323
46. Malmsjo, M; Hou, MY; Harden, TK; Pendergast, W; Pantev, E; Edvinsson, L; Erlinge, D
    Characterization of contractile P2 receptors in human coronary arteries byuse of the stable pyrimidines uridine 5 '-O-thiodiphosphate and uridine 5 '-O-3-thiotriphosphate
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M. Malmsjo et al., "Characterization of contractile P2 receptors in human coronary arteries byuse of the stable pyrimidines uridine 5 '-O-thiodiphosphate and uridine 5 '-O-3-thiotriphosphate", J PHARM EXP, 293(3), 2000, pp. 755-760
47. Dangelmaier, C; Jin, JG; Daniel, JL; Smith, JB; Kunapuli, SP
    The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    C. Dangelmaier et al., "The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets", EUR J BIOCH, 267(8), 2000, pp. 2283-2289
48. Malmsjo, M; Adner, M; Harden, TK; Pendergast, W; Edvinsson, L; Erlinge, D
    The stable pyrimidines UDP beta S and UTP gamma S discriminate between theP2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M. Malmsjo et al., "The stable pyrimidines UDP beta S and UTP gamma S discriminate between theP2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery", BR J PHARM, 131(1), 2000, pp. 51-56
49. Mahaut-Smith, MP; Ennion, SJ; Rolf, MG; Evans, RJ
    ADP is not an agonist at P2X(1) receptors: evidence for separate receptorsstimulated by ATP and ADP on human platelets
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M.P. Mahaut-Smith et al., "ADP is not an agonist at P2X(1) receptors: evidence for separate receptorsstimulated by ATP and ADP on human platelets", BR J PHARM, 131(1), 2000, pp. 108-114
50. Filippov, AK; Brown, DA; Barnard, EA
    The P2Y(1) receptor closes the N-type Ca2+ channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists
    BRITISH JOURNAL OF PHARMACOLOGY
    
    A.K. Filippov et al., "The P2Y(1) receptor closes the N-type Ca2+ channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists", BR J PHARM, 129(6), 2000, pp. 1063-1066
51. Lenz, G; Gottfried, C; Luo, ZJ; Avruch, J; Rodnight, R; Nie, WJ; Kang, Y; Neary, JT
    P-2Y purinoceptor subtypes recruit different Mek activators in astrocytes
    BRITISH JOURNAL OF PHARMACOLOGY
    
    G. Lenz et al., "P-2Y purinoceptor subtypes recruit different Mek activators in astrocytes", BR J PHARM, 129(5), 2000, pp. 927-936
52. Storey, RF; Sanderson, HM; White, AE; May, JA; Cameron, KE; Heptinstall, S
    The central role of the P-2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R.F. Storey et al., "The central role of the P-2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity", BR J HAEM, 110(4), 2000, pp. 925-934
53. Ohlmann, P; Eckly, A; Freund, M; Cazenave, JP; Offermanns, S; Gachet, C
    ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of G alpha q
    BLOOD
    
    P. Ohlmann et al., "ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of G alpha q", BLOOD, 96(6), 2000, pp. 2134-2139
54. Gratacap, MP; Herault, JP; Viala, C; Ragab, A; Savi, P; Herbert, JM; Chap, H; Plantavid, M; Payrastre, B
    Fc gamma RIIA requires a Gi-dependent pathway for an efficient stimulationof phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation
    BLOOD
    
    M.P. Gratacap et al., "Fc gamma RIIA requires a Gi-dependent pathway for an efficient stimulationof phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation", BLOOD, 96(10), 2000, pp. 3439-3446
55. Sak, K; Raidaru, G; Webb, TE; Jarv, J
    Phosphate-substituted ATP analogs are antagonists at human P2Y(1) purinoceptors
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    
    K. Sak et al., "Phosphate-substituted ATP analogs are antagonists at human P2Y(1) purinoceptors", ARCH BIOCH, 381(1), 2000, pp. 171-172
56. Cattaneo, M; Gachet, C
    ADP receptors and clinical bleeding disorders
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    M. Cattaneo e C. Gachet, "ADP receptors and clinical bleeding disorders", ART THROM V, 19(10), 1999, pp. 2281-2285
57. Fabre, JE; Nguyen, MT; Latour, A; Keifer, JA; Audoly, LP; Coffman, TM; Koller, BH
    Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y(1)-deficient mice
    NATURE MEDICINE
    
    J.E. Fabre et al., "Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y(1)-deficient mice", NAT MED, 5(10), 1999, pp. 1199-1202
58. Kim, YB; Jin, JG; Dangelmaier, C; Daniel, JL; Kunapuli, SP
    The P2Y1 receptor is essential for ADP-induced shape change and aggregation in mouse platelets
    PLATELETS
    
    Y.B. Kim et al., "The P2Y1 receptor is essential for ADP-induced shape change and aggregation in mouse platelets", PLATELETS, 10(6), 1999, pp. 399-406
59. Liu, QD; Sloan, S; Frojmovic, MM
    ATP does not affect fibrinogen binding to platelet GPIIbIIIa in systems free of signal transduction
    PLATELETS
    
    Q.D. Liu et al., "ATP does not affect fibrinogen binding to platelet GPIIbIIIa in systems free of signal transduction", PLATELETS, 10(6), 1999, pp. 407-416
60. Weber, AA; Hohlfeld, T; Schror, K
    cAMP is an important messenger for ADP-induced platelet aggregation
    PLATELETS
    
    A.A. Weber et al., "cAMP is an important messenger for ADP-induced platelet aggregation", PLATELETS, 10(4), 1999, pp. 238-241
61. Koziak, K; Sevigny, J; Robson, SC; Siegel, JB; Kaczmarek, E
    Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes
    THROMBOSIS AND HAEMOSTASIS
    
    K. Koziak et al., "Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes", THROMB HAEM, 82(5), 1999, pp. 1538-1544
62. Daniel, JL; Dangelmaier, C; Jin, JG; Kim, YB; Kunapuli, SP
    Role of intracellular signaling events in ADP-induced platelet aggregation
    THROMBOSIS AND HAEMOSTASIS
    
    J.L. Daniel et al., "Role of intracellular signaling events in ADP-induced platelet aggregation", THROMB HAEM, 82(4), 1999, pp. 1322-1326
63. Schwarz, UR; Geiger, J; Walter, U; Eigenthaler, M
    Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - Definition and detection of ticlopidine/clopidogrel effects
    THROMBOSIS AND HAEMOSTASIS
    
    U.R. Schwarz et al., "Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - Definition and detection of ticlopidine/clopidogrel effects", THROMB HAEM, 82(3), 1999, pp. 1145-1152
64. Shattil, SJ
    Signaling through platelet integrin alpha IIb beta 3: Inside-out, outside-in, and sideways
    THROMBOSIS AND HAEMOSTASIS
    
    S.J. Shattil, "Signaling through platelet integrin alpha IIb beta 3: Inside-out, outside-in, and sideways", THROMB HAEM, 82(2), 1999, pp. 318-325
65. Jantzen, HM; Gousset, L; Bhaskar, V; Vincent, D; Tai, A; Reynolds, EE; Conley, PB
    Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation
    THROMBOSIS AND HAEMOSTASIS
    
    H.M. Jantzen et al., "Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation", THROMB HAEM, 81(1), 1999, pp. 111-117
66. Yu, HX; Bianchi, B; Metzger, R; Lynch, KJ; Kowaluk, EA; Jawis, MF; van Biesen, T
    Lack of specificity of [S-35]-ATP gamma S and [S-35]-ADP beta S as radioligands for ionotropic and metabotropic P2 receptor binding
    DRUG DEVELOPMENT RESEARCH
    
    H.X. Yu et al., "Lack of specificity of [S-35]-ATP gamma S and [S-35]-ADP beta S as radioligands for ionotropic and metabotropic P2 receptor binding", DRUG DEV R, 48(2), 1999, pp. 84-93
67. Jacobson, KA; Hoffmann, C; Kim, YC; Camaioni, E; Nandanan, E; Jang, SY; Guo, DP; Ji, XD; von Kugelgen, I; Moro, S; Ziganshin, AU; Rychkov, A; King, BF; Brown, SG; Wildman, SS; Burnstock, G; Boyer, JL; Mohanram, A; Harden, TK
    Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis
    NUCLEOTIDES AND THEIR RECEPTORS IN THE NERVOUS SYSTEMS
    
    K.A. Jacobson et al., "Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis", PROG BRAIN, 120, 1999, pp. 119-132
68. Major, DT; Halbfinger, E; Fischer, B
    Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 2. A computational approach
    JOURNAL OF MEDICINAL CHEMISTRY
    
    D.T. Major et al., "Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 2. A computational approach", J MED CHEM, 42(26), 1999, pp. 5338-5347
69. Fischer, B; Chulkin, A; Boyer, JL; Harden, KT; Gendron, FP; Beaudoin, AR; Chapal, J; Hillaire-Buys, D; Petit, P
    2-thioether 5 '-O-(1-thiotriphosphate)adenosine derivatives as new insulinsecretagogues acting through P2Y-receptors
    JOURNAL OF MEDICINAL CHEMISTRY
    
    B. Fischer et al., "2-thioether 5 '-O-(1-thiotriphosphate)adenosine derivatives as new insulinsecretagogues acting through P2Y-receptors", J MED CHEM, 42(18), 1999, pp. 3636-3646
70. Takano, S; Kimura, J; Matsuoka, I; Ono, T
    No requirement of P2X1 purinoceptors for platelet aggregation
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    S. Takano et al., "No requirement of P2X1 purinoceptors for platelet aggregation", EUR J PHARM, 372(3), 1999, pp. 305-309
71. Dol-Gleizes, F; Mares, AM; Savi, P; Herbert, JM
    Relaxant effect of 2-methyl-thio-adenosine diphosphate on rat thoracic aorta: effect of clopidogrel
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    F. Dol-Gleizes et al., "Relaxant effect of 2-methyl-thio-adenosine diphosphate on rat thoracic aorta: effect of clopidogrel", EUR J PHARM, 367(2-3), 1999, pp. 247-253
72. Quinn, MJ; Fitzgerald, DJ
    Ticlopidine and clopidogrel
    CIRCULATION
    
    M.J. Quinn e D.J. Fitzgerald, "Ticlopidine and clopidogrel", CIRCULATION, 100(15), 1999, pp. 1667-1672
73. McMillan, MR; Burnstock, G; Haworth, SG
    Vasodilatation of intrapulmonary arteries to P2-receptor nucleotides in normal and pulmonary hypertensive newborn piglets
    BRITISH JOURNAL OF PHARMACOLOGY
    
    M.R. McMillan et al., "Vasodilatation of intrapulmonary arteries to P2-receptor nucleotides in normal and pulmonary hypertensive newborn piglets", BR J PHARM, 128(3), 1999, pp. 543-548
74. Anwar, Z; Albert, JL; Gubby, SE; Boyle, JP; Roberts, JA; Webb, TE; Boarder, MR
    Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells
    BRITISH JOURNAL OF PHARMACOLOGY
    
    Z. Anwar et al., "Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells", BR J PHARM, 128(2), 1999, pp. 465-471
75. Park, HS; Hourani, SMO
    Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5 '-diphospbate (ADP) in human platelets
    BRITISH JOURNAL OF PHARMACOLOGY
    
    H.S. Park e S.M.O. Hourani, "Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5 '-diphospbate (ADP) in human platelets", BR J PHARM, 127(6), 1999, pp. 1359-1366
76. Trumel, C; Payrastre, B; Plantavid, M; Hechler, B; Viala, C; Presek, P; Martinson, EA; Cazenave, JP; Chap, H; Gachet, C
    A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase
    BLOOD
    
    C. Trumel et al., "A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase", BLOOD, 94(12), 1999, pp. 4156-4165
77. WEBB TE; SIMON J; BARNARD EA
    REGIONAL DISTRIBUTION OF [S-35] 2'-DEOXY 5'-O-(1-THIO) ATP BINDING-SITES AND THE P2Y(1) MESSENGER-RNA WITHIN THE CHICK BRAIN
    Neuroscience
    
    T.E. Webb et al., "REGIONAL DISTRIBUTION OF [S-35] 2'-DEOXY 5'-O-(1-THIO) ATP BINDING-SITES AND THE P2Y(1) MESSENGER-RNA WITHIN THE CHICK BRAIN", Neuroscience, 84(3), 1998, pp. 825-837
78. Kunapuli, SP
    Molecular physiology of platelet ADP receptors
    DRUG DEVELOPMENT RESEARCH
    
    S.P. Kunapuli, "Molecular physiology of platelet ADP receptors", DRUG DEV R, 45(3-4), 1998, pp. 135-139
79. Park, HS; Tennant, JP; Waktolla, GF; Sarkardei, S; Kass, GEN; Hourani, SMO
    Effects of adenosine 3 '-phosphate 5 '-phosphosulfate on P2 receptors in platelets and smooth muscle preparations
    DRUG DEVELOPMENT RESEARCH
    
    H.S. Park et al., "Effects of adenosine 3 '-phosphate 5 '-phosphosulfate on P2 receptors in platelets and smooth muscle preparations", DRUG DEV R, 45(2), 1998, pp. 67-73
80. SAVI P; BEAUVERGER P; LABOURET C; DELFAUD M; SALEL V; KAGHAD M; HERBERT JM
    ROLE OF P2Y1 PURINOCEPTOR IN ADP-INDUCED PLATELET ACTIVATION
    FEBS letters
    
    P. Savi et al., "ROLE OF P2Y1 PURINOCEPTOR IN ADP-INDUCED PLATELET ACTIVATION", FEBS letters, 422(3), 1998, pp. 291-295
81. BOYER JL; MOHANRAM A; CAMAIONI E; JACOBSON KA; HARDEN TK
    COMPETITIVE AND SELECTIVE ANTAGONISM OF P2Y(1) RECEPTORS BY N-6-METHYL 2'-DEOXYADENOSINE 3',5'-BISPHOSPHATE
    British Journal of Pharmacology
    
    J.L. Boyer et al., "COMPETITIVE AND SELECTIVE ANTAGONISM OF P2Y(1) RECEPTORS BY N-6-METHYL 2'-DEOXYADENOSINE 3',5'-BISPHOSPHATE", British Journal of Pharmacology, 124(1), 1998, pp. 1-3
82. KUNAPULI SP
    MULTIPLE P2 RECEPTOR SUBTYPES ON PLATELETS - A NEW INTERPRETATION OF THEIR FUNCTION
    Trends in pharmacological sciences
    
    S.P. Kunapuli, "MULTIPLE P2 RECEPTOR SUBTYPES ON PLATELETS - A NEW INTERPRETATION OF THEIR FUNCTION", Trends in pharmacological sciences, 19(10), 1998, pp. 391-394
83. SCHACHTER JB; SROMEK SM; NICHOLAS RA; HARDEN TK
    HEK293 HUMAN EMBRYONIC KIDNEY-CELLS ENDOGENOUSLY EXPRESS THE P2Y(1) AND P2Y(2) RECEPTORS
    Neuropharmacology
    
    J.B. Schachter et al., "HEK293 HUMAN EMBRYONIC KIDNEY-CELLS ENDOGENOUSLY EXPRESS THE P2Y(1) AND P2Y(2) RECEPTORS", Neuropharmacology, 36(9), 1997, pp. 1181-1187
84. SIMON J; WEBB TE; BARNARD EA
    DISTRIBUTION OF [S-35]DATP-ALPHA-S BINDING SITES IN THE ADULT RAT NEURAXIS
    Neuropharmacology
    
    J. Simon et al., "DISTRIBUTION OF [S-35]DATP-ALPHA-S BINDING SITES IN THE ADULT RAT NEURAXIS", Neuropharmacology, 36(9), 1997, pp. 1243-1251
85. SCHACHTER JB; BOYER JL; LI Q; NICHOLAS RA; HARDEN TK
    FIDELITY IN FUNCTIONAL COUPLING OF THE RAT P2Y(1) RECEPTOR TO PHOSPHOLIPASE-C
    British Journal of Pharmacology
    
    J.B. Schachter et al., "FIDELITY IN FUNCTIONAL COUPLING OF THE RAT P2Y(1) RECEPTOR TO PHOSPHOLIPASE-C", British Journal of Pharmacology, 122(6), 1997, pp. 1021-1024
86. SCHACHTER JB; HARDEN TK
    AN EXAMINATION OF DEOXYADENOSINE 5'(ALPHA-THIO)TRIPHOSPHATE AS A LIGAND TO DEFINE P2Y RECEPTORS AND ITS SELECTIVITY AS A LOW POTENCY PARTIAL AGONIST OF THE P2Y(1) RECEPTOR
    British Journal of Pharmacology
    
    J.B. Schachter e T.K. Harden, "AN EXAMINATION OF DEOXYADENOSINE 5'(ALPHA-THIO)TRIPHOSPHATE AS A LIGAND TO DEFINE P2Y RECEPTORS AND ITS SELECTIVITY AS A LOW POTENCY PARTIAL AGONIST OF THE P2Y(1) RECEPTOR", British Journal of Pharmacology, 121(2), 1997, pp. 338-344